$BFRI

$1.47▲ -5.2% YTD

3 SEC 13D/G filings tracked · Last updated Sep 14, 2026

Filing History

CP $1.47▲ -5.2%Sep 14, 2026 · ThinkSabio Blog

$BFRI BFRIW - Biofrontera Announces FDA Approval of Ameluz® Red Light PDT for the Treatment of Superficial Basal Cell Carcinoma…

News

BFRI ▼ -4.5% - Biofrontera Inc.

CP $1.47▲ -4.5%Sep 10, 2026 · ThinkSabio Blog

$BFRI - Biofrontera has received FDA approval of Ameluz used in combination with the RhodoLED (SM Circulations)…

SEC 13D/G

BFRI - Biofrontera Inc. - SEC Filing Update (12-AUG-2026) | ThinkSabio - Stocks Simplified

$1.24▲ 72.22%Aug 12, 2026 · ThinkSabio Blog

$BFRI SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #BFRI Biofrontera Inc. : $1.24 Sector: Healthcare | YTD: 🔼+ 72.2…